Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.
Melphalan inhibits the incorporation of 3H-thymidine and 3H-uridine significantly more in phytohaemagglutinin (PHA)-stimulated human lymphocytes than in a human melanoma cell line (RPMI 8322). Melphalan - induced total DNA cross-linking was 1.7 times higher and DNA interstrand cross-linking was 1.8 times higher in the PHA-stimulated lymphocytes than in the melanoma cells. A higher level of DNA cross-linking was required in melanoma cells than in PHA-stimulated lymphocytes to obtain similar levels of inhibition of incorporation of 3H-thymidine and 3H-uridine. The outflow of cells from G1 to S phase was significantly more inhibited by melphalan in the lymphocytes than in the melanoma cells. Thus the melanoma cells can replicate and transcribe DNA in the presence of levels of DNA damage, which in PHA-stimulated lymphocytes strongly inhibit DNA and RNA synthesis.
Ringborg
U
U
Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.
Hansson
J
J
Jungnelius
U
U
Lewensohn
R
R
Skog
S
S
D004249:DNA Damage; D004261:DNA Replication / Q000187:drug effects*; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000187:drug effects*; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects*; D008545:Melanoma / Q000235:genetics*; D008558:Melphalan / Q000494:pharmacology*; D010835:Phytohemagglutinins / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis*
D004273:DNA, Neoplasm; D010835:Phytohemagglutinins; D012334:RNA, Neoplasm; D008558:Melphalan